当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3570783
自主品牌
已选条件
-
T6587Mitiglinide CalciumS 21403,Potassium Channel,type,KAD 1229,Mitiglinide Calcium,diabetes,hypoglycaemi
Mitiglinide Calcium is a blood glucose-lowering drugs, stimulating insulin secretion by closing the ATP-sensitive K+ channels in pancreatic beta-cells.
价 格：￥电议型 号：T6587产 地：中国大陆
-
T1530Mitiglinide calcium hydrate米格列奈钙；S-21403 calcium hydrate；KAD-1229 calcium hydrate；Mitiglinide calciu
Mitiglinide calcium dihydrate is a drug for the treatment of type 2 diabetes. Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive K(+) K(ATP) channels in pancreatic beta-cells. Mitiglinide belongs to the meglitinide class of
价 格：￥电议型 号：T1530产 地：中国大陆
-
T1530Mitiglinide calciumMitiglinide calcium,S-21403 calcium hydrate,KAD-1229 calcium hydrate
Mitiglinide is a drug for the treatment of type 2 diabetes. Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive K(+) K(ATP) channels in pancreatic beta-cells. Mitiglinide belongs to the meglitinide class of blood glucose-low
价 格：￥电议型 号：T1530产 地：美洲
-
T6587Mitiglinide Calcium米格列奈钙KAD-1229|||米格列奈钙|||S21403|||米格列奈
Mitiglinide Calcium (KAD-1229) is a blood glucose-lowering drugs, stimulating insulin secretion by closing the ATP-sensitive K+ channels in pancreatic beta-cells.
价 格：￥电议型 号：T6587产 地：中国大陆
-
T21431Mitiglinide；化合物 T21431Mitiglinide
Mitiglinide (KAD-1229) is an insulinotropic agent that is an ATP-sensitive K + (K ATP ) channel antagonist. Mitiglinide is highly specific to the Kir6.2/SUR1 complex (the pancreatic beta-cell K ATP channel). Mitiglinide is able to be used for the research of type 2 diabetes [1] [2].
价 格：￥电议型 号：T21431产 地：中国大陆
-
T1530Mitiglinide calcium hydrate；米格列奈钙KAD-1229 calcium hydrate|||Mitiglinide calcium|||S-21403 calcium hy
Mitiglinide calcium hydrate (S-21403 calcium hydrate) is a drug for the treatment of type 2 diabetes. Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive K(+) K(ATP) channels in pancreatic beta-cells. Mitiglinide belongs to the meglitinide class of blood glucose-lowering drugs and is currently co-marketed in Japan by Kissei and Takeda.
价 格：￥电议型 号：T1530产 地：中国大陆
